Metavia INC. (MTVA) SEC Filings — 2024
37 SEC filings for Metavia INC. (MTVA) in 2024.
Filings
- MetaVia Inc. Files 8-K Report — 8-K · Dec 18, 2024
- MetaVia Inc. Files 8-K — 8-K · Nov 29, 2024
- NeuroBo Pharmaceuticals Files 8-K with Corporate Updates — 8-K · Nov 18, 2024
- Neurobo Pharmaceuticals, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- NeuroBo Pharma Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Nov 4, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Oct 7, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Sep 30, 2024
- Dong-A ST Amends NeuroBo Pharmaceuticals Stake — SC 13D/A · Sep 20, 2024
- NeuroBo Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Sep 19, 2024
- NeuroBo Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Aug 21, 2024
- NeuroBo Pharma Q2 2024: Assets $8.2M, Liabilities $4.9M — 10-Q · Aug 14, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Aug 13, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Aug 6, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Jul 30, 2024
- NeuroBo Pharma Files S-1 for Potential Offering — S-1 · Jul 18, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Jul 16, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Jun 26, 2024
- NeuroBo Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 25, 2024
- Dong-A ST Files 13D/A for NeuroBo Pharmaceuticals — SC 13D/A · Jun 25, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Jun 24, 2024
- NeuroBo Pharmaceuticals Appoints New Officers and Directors — 8-K · Jun 7, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · May 22, 2024
- NeuroBo Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- NeuroBo Pharmaceuticals Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 30, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Apr 30, 2024
- NeuroBo Pharmaceuticals Files 8-K Report — 8-K · Apr 17, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Apr 16, 2024
- NeuroBo Pharmaceuticals Files 8-K — 8-K · Apr 1, 2024
- NeuroBo Pharmaceuticals, Inc. Files 2023 Annual Report (10-K) — 10-K · Mar 28, 2024
- NeuroBo Pharmaceuticals Files 8-K Report — 8-K · Mar 13, 2024
- NeuroBo Pharmaceuticals Appoints New Director and CMO — 8-K · Mar 4, 2024
- NeuroBo Pharma Files 8-K on 'Other Events' and Financial Exhibits — 8-K · Feb 29, 2024
- NeuroBo Pharmaceuticals Files 8-K for 'Other Events' on Feb 14 — 8-K · Feb 14, 2024
- NeuroBo Pharma Files Routine 8-K on Feb 1, No New Material Events — 8-K · Feb 1, 2024
- NeuroBo Pharma Files Routine 8-K, Updates Corporate Info — 8-K · Jan 18, 2024
- NeuroBo Pharma Files Routine 8-K on Jan 8 Event — 8-K · Jan 9, 2024